Psychometric validation of the Chinese version of the M. D. Anderson Symptom Inventory-Head and Neck Module in patients with nasopharyngeal carcinoma

被引:1
|
作者
Xiao, Wenli [1 ]
Chan, Carmen W. H. [2 ]
Wang, Xin Shelley [3 ]
Xiao, Jinnan [4 ]
Ng, Marques S. N. [2 ,5 ]
机构
[1] Guangzhou Univ Chinese Med, Sch Nursing, Guangzhou, Peoples R China
[2] Chinese Univ Hong Kong, Nethersole Sch Nursing, Hong Kong, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
[4] Cent South Univ, Xiangya Sch Nursing, Changsha, Peoples R China
[5] Chinese Univ Hong Kong, Hong Kong, Peoples R China
关键词
Nasopharyngeal carcinoma; Head and neck cancer; Symptom burden; MDASI-HN; Validation; QUALITY-OF-LIFE; CANCER-PATIENTS; PSYCHOEDUCATIONAL INTERVENTION; TAIWANESE VERSION; DISTRESS; UTILITY; RADIOTHERAPY; INSTRUMENT; SURVIVORS; CLUSTERS;
D O I
10.1016/j.apjon.2021.12.014
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective:The Chinese version of the M. D. Anderson Symptom Inventory-Head and Neck Module (MDASI-HN-C) has been linguistically validated. However, its psychometric properties have not been established yet. The purpose of the study was to psychometrically validate the MDASI-HN-C in patients with nasopharyngeal carcinoma (NPC). Methods:130 Chinese NPC patients who were undergoing radiotherapy (RT) participated in this cross-sectional study. The content, convergent, and construct validity of the MDASI-HN-C were examined. The reliability of the instrument was tested by examining the internal consistency and test-retest reliability. Results:Cronbach's alpha coefficients ranged from 0.85 to 0.91 for the three subscales of the MDASI-HN-C. The 3-day test-retest reliability was acceptable with intraclass correlation coefficients (ICC) ranged from 0.52 to 0.71. The scale content validity index (S-CVI) was satisfactory (0.97). Subscale scores of the MDASI-HN-C were negatively correlated with the total score of the Chinese version of the Functional Assessment of Cancer Therapy-Head and Neck Scale (FACT-H&N-C) as hypothesized (r 1/4 -0.484 to -0.563, all P < 0.01). Exploratory factor analysis (EFA) revealed two factors for the 13 core and another two for the nine HNC-specific items. Only one factor was generated for the six interference items. Conclusions:The MDASI-HN-C shows desirable psychometric properties for evaluating symptom burden in NPC patients, which can be used in both clinical and research contexts.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 50 条
  • [31] Validation and Application of a Module of the M. D. Anderson Symptom Inventory for Measuring Multiple Symptoms in Patients With Gastrointestinal Cancer (the MDASI-GI)
    Wang, Xin Shelley
    Williams, Loretta A.
    Eng, Cathy
    Mendoza, Tito R.
    Shah, Nyma A.
    Kirkendoll, Karyn J.
    Shah, Pankil K.
    Trask, Peter C.
    Palos, Guadalupe R.
    Cleeland, Charles S.
    CANCER, 2010, 116 (08) : 2053 - 2063
  • [32] Reliability and validity of the M. D. Anderson Symptom Inventory Spine Tumor Module Clinical article
    Armstrong, Terri S.
    Gning, Ibrahima
    Mendoza, Tito R.
    Vera-Bolanos, Elizabeth
    Gilbert, Mark R.
    Rhines, Laurence D.
    Weinberg, Jeffrey S.
    Sanchez-Williams, Gisela
    Levin, Victor
    Burton, Allen W.
    Cleeland, Charles
    JOURNAL OF NEUROSURGERY-SPINE, 2010, 12 (04) : 421 - 430
  • [33] Cancer-Related Symptom Assessment in France: Validation of the French M. D. Anderson Symptom Inventory
    Guirimand, Frederic
    Buyck, Jean-Francois
    Lauwers-Allot, Elisabeth
    Revnik, Julia
    Kerguen, Thierry
    Aegerter, Philippe
    Brasseur, Louis
    Cleeland, Charles S.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 39 (04) : 721 - 733
  • [34] Prospective Validation and Instrumental Comparison of the MD Anderson Symptom Inventory-Head and Neck Module for Assessment of Radiation Therapy-Attributable Late Xerostomia
    Kamal, M.
    Dursteler, A.
    O'Donnell, B. P.
    Eraj, S.
    Mohamed, A. S. R.
    Cardenas, C.
    Meheissen, M. A. M.
    Garden, A. S.
    Mendoza, T. R.
    Sturgis, E. M.
    Hutcheson, K. A.
    Lu, C.
    Aristophanous, M.
    Frank, S. J.
    Morrison, W. H.
    Rosenthal, D. I.
    Fuller, C. D.
    Gunn, G. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E538 - E538
  • [35] Cross-Cultural Adaptation and Validation of the Persian Version of the M. D. Anderson Dysphagia Inventory
    Sharifi, Fardin
    Qoreishi, Zahra Sadat
    Bakhtiyari, Jalal
    Ebadi, Abbas
    Houshyari, Mohammad
    Azghandi, Samira
    INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, 2024, 28 (02) : e288 - e293
  • [36] Validation of Portuguese version of the MD Anderson Symptom Inventory (MDASI) for patients with head and neck cancer.
    Castro, Ana Filipa Martins Ferreira
    Febra, Joana
    Amorim, Andreina
    Coelho, Andreia Machado
    De Araujo, Alexandra Vieira
    Ferreira, Maria Gloria
    Araujo, Antonio M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Symptom Burden of Cancer Patients: Validation of the German M. D. Anderson Symptom Inventory: A Cross-Sectional Multicenter Study
    Schmidt, Heike
    Cleeland, Charles S.
    Bauer, Alexander
    Landenberger, Margarete
    Jahn, Patrick
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (01) : 118 - 126
  • [38] Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer
    Sailors, Mary H.
    Bodurka, Diane C.
    Gning, Ibrahima
    Ramondetta, Lois M.
    Williams, Loretta A.
    Mendoza, Tito R.
    Agarwal, Sonika
    Sun, Charlotte C.
    Cleeland, Charles S.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 323 - 328
  • [39] Assessing Cancer Symptoms in Adolescents With Cancer Using the Taiwanese Version of the M. D. Anderson Symptom Inventory
    Tseng, Tsui-Hwa
    Cleeland, Charles S.
    Wang, Xin Shelley
    Lin, Chia-Chin
    CANCER NURSING, 2008, 31 (03) : E9 - E16
  • [40] Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory
    Mendoza, Tito R.
    Wang, Xin Shelley
    Lu, Charles
    Palos, Guadalupe R.
    Liao, Zhongxing
    Mobley, Gary M.
    Kapoor, Shitij
    Cleeland, Charles S.
    ONCOLOGIST, 2011, 16 (02): : 217 - 227